Growth Metrics

Pfizer (PFE) Operating Margin (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -31,047.00
Dec 31, 2025 36,494.00
Sep 28, 2025 -1,890.00
Jun 29, 2025 -796.00
Sep 29, 2024 -250,182.00
Jun 30, 2024 -1,841.00
Mar 31, 2024 41,875.00
Dec 31, 2023 45,537.00
Oct 1, 2023 -66,436.00
Jul 2, 2023 2,402.00
Oct 2, 2022 -146.00
Jul 3, 2022 574.00
Oct 3, 2021 -289.00
Jul 4, 2021 -270.00
Sep 27, 2020 224.00
Jun 28, 2020 -853.00
Sep 29, 2019 -620.00
Jun 30, 2019 -163.00
Mar 31, 2019 48,658.00
Dec 31, 2018 -48,200.00
Sep 30, 2018 -1.00
Jul 1, 2018 -149.00
Apr 1, 2018 -3,515.00
Dec 31, 2017 -353.00
Oct 1, 2017 -118.00
Jul 2, 2017 -173.00
Apr 2, 2017 401.00
Dec 31, 2016 84.00
Oct 2, 2016 101.00
Jul 3, 2016 -306.00
Apr 3, 2016 246.00
Dec 31, 2015 -488.00
Sep 27, 2015 4.00
Jun 28, 2015 -265.00
Mar 29, 2015 6,048.00
Dec 31, 2014 -1,445.00
Sep 28, 2014 -111.00
Jun 29, 2014 -180.00
Mar 30, 2014 877.00
Dec 31, 2013 -886.00
Sep 29, 2013 -144.00
Jun 30, 2013 108.00
Mar 31, 2013 1,382.00
Dec 31, 2012 -1,106.00
Sep 30, 2012 -573.00
Jul 1, 2012 694.00
Apr 1, 2012 898.00
Dec 31, 2011 -492.00
Oct 2, 2011 -150.00
Jul 3, 2011 224.00
Apr 3, 2011 2,408.00
Dec 31, 2010 -2,259.00
Oct 3, 2010 -198.00
Jul 4, 2010 -180.00
Apr 4, 2010 3,448.00
Dec 31, 2009 -4,060.00
Sep 27, 2009 416.00
Jun 28, 2009 -329.00